Infectious Diseases

doctors wearing scrubs with red aids awareness ribbons pinned to shirts
December 4, 2023

Report offers a way to overcome the severe lack of HIV providers

In a new report, members of the Southeast AIDS Education and Training Center, which is coordinated by Vanderbilt University Medical Center, offers an innovative approach to increasing the HIV workforce: train all manner of health professionals to care for people with HIV.

By Bill Snyder
A C. diff bacterium (green) with iron particles in red, shown in a reconstructed electron tomogram from STEM-EDS. (image courtesy of James McBride)
November 15, 2023

Novel C. diff structures are required for infection, offer new therapeutic targets

Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs.

By Leigh MacMillan
November 13, 2023

Study finds antiviral treatment is largely underused in children with influenza

Vanderbilt research finds antiviral medications are underused in young children diagnosed with influenza despite national guidelines supporting their use

By Jessica Pasley
November 8, 2023

Flu season starting late but expected to increase for the holidays

The current flu season has started later and more gradually than last year although cases are expected to begin increasing in November before falling off in March.

By Courtney Graetzer
October 16, 2023

ICU antibiotics may be safe for kidneys

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.

By Craig Boerner
Sage Davis, 4, observes microbial “snakes” and “space bears” (tardigrades) under the microscope with his parents, Corinne and Gerald.
September 29, 2023

Educational event zooms in on complex world of microbes

More than 100 children and their families attended the sixth annual MEGAMicrobe community science recently at Gower Elementary School in Nashville.

By Bill Snyder
August 15, 2023

Study finds most infants receiving ICU-level care for RSV had no underlying medical condition

A Vanderbilt study found that most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term.
By Jessica Pasley
August 4, 2023

Researchers discover antibody that neutralizes both RSV and hMPV

Vanderbilt and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus and human metapneumovirus.
By Anthony Czelusniak
July 24, 2023

Study explores how often children diagnosed with flu experience serious neuropsychiatric side effects

A Vanderbilt study is among the first to quantify how often children diagnosed with flu experience serious neuropsychiatric side effects.
By Jessica Pasley
April 24, 2023

Study finds early RSV infection linked to significantly increased risk of asthma in children

A Vanderbilt study has found that RSV infection in the first year of life is associated with a significantly increased risk of asthma in children.
By Nancy Humphrey
April 24, 2023

Novel drugs have potential for treating tuberculosis

Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.
By Leigh MacMillan
April 20, 2023

Study details RNA editing in virus-infected cancer cells

Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection.
By Leigh MacMillan
March 30, 2023

NIH grant launches C. diff vaccine research initiative

Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV.
By Anthony Czelusniak
1 … 3 4 5 6 7 … 12